Published in Lancet Oncol on January 01, 2012
Drugs for solid cancer: the productivity crisis prompts a rethink. Onco Targets Ther (2013) 0.78
Pragmatic medicine in solid cancer: a translational alternative to precision medicine. Onco Targets Ther (2016) 0.75
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci (2003) 2.52
Global impact of oncogenic Src on a phosphotyrosine proteome. J Proteome Res (2008) 1.94
The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell Mol Life Sci (2009) 1.52
Regulation and localization of CAS substrate domain tyrosine phosphorylation. Cell Signal (2004) 1.47
Contractile forces in tumor cell migration. Eur J Cell Biol (2008) 1.31
Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res (2008) 1.14
The structure of invadopodia in a complex 3D environment. Eur J Cell Biol (2010) 1.05
Limits to Precision Cancer Medicine. N Engl J Med (2017) 0.95
Invasive cells in animals and plants: searching for LECA machineries in later eukaryotic life. Biol Direct (2013) 0.92
Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness. Mol Biol Cell (2011) 0.90
ROCK inhibitors as emerging therapeutic candidates for sarcomas. Curr Cancer Drug Targets (2010) 0.88
New tools for cancer chemotherapy: computational assistance for tailoring treatments. Mol Cancer Ther (2003) 0.88
CAS directly interacts with vinculin to control mechanosensing and focal adhesion dynamics. Cell Mol Life Sci (2013) 0.86
Cytostatic anticancer drug development. J Exp Ther Oncol (2004) 0.84
Metastasis of aggressive amoeboid sarcoma cells is dependent on Rho/ROCK/MLC signaling. Cell Commun Signal (2013) 0.83
SH3 domain tyrosine phosphorylation--sites, role and evolution. PLoS One (2012) 0.83
Neoplastic progression of the human breast cancer cell line G3S1 is associated with elevation of cytoskeletal dynamics and upregulation of MT1-MMP. Int J Oncol (2010) 0.82
NG2-mediated Rho activation promotes amoeboid invasiveness of cancer cells. Eur J Cell Biol (2012) 0.79
Drugs for solid cancer: the productivity crisis prompts a rethink. Onco Targets Ther (2013) 0.78
Prediction of cancer outcome with microarrays. Lancet (2005) 0.75
Posterior capsular opacification with hydrogel, polymethylmethacrylate, and silicone intraocular lenses: two-year results of a randomized prospective trial. Am J Ophthalmol (2002) 0.75
Correcting Hatch-Waxman. Health Aff (Millwood) (2008) 0.75
Haemoglobin concentrations in chronic kidney disease. Lancet (2007) 0.75
Confocal microscopy reveals Myzitiras and Vthela morphotypes as new signatures of malignancy progression. Scanning (2009) 0.75